Author/Authors :
Schirrmacher، نويسنده , , Esther and Schirrmacher، نويسنده , , Ralf and Beck، نويسنده , , Carmen and Mier، نويسنده , , Walter and Trautman، نويسنده , , Norbert and Rِsch، نويسنده , , Frank، نويسنده ,
Abstract :
A novel Tyr3-octreotate conjugated closo-carborane as a potential compound for boron neutron capture therapy was obtained via Fmoc solid phase peptide synthesis. The boron cluster [C2B10H11] was introduced through the reaction of 6,9-bis(acetonitrile)decaborane and 5-hexynoic acid yielding a new closo-carborane conjugated carboxylic acid which was coupled subsequently with solid phase conjugated Tyr3-octreotate. The final boron-containing peptide was purified by preparative reverse phase HPLC and structural identity was proved applying MALDI-TOF mass spectrometry.
Keywords :
closo-carborane , TYr3-Octreotate , boron neutron capture therapy (BNCT) , Somatostatin receptor